Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Nothing in this article constitutes medical advice
Early animal and human studies have reported encouraging findings, but evidence from large and diverse populations remains limited
Tirzepatide Tirzepatide acts as a dual GLP-1/GIP receptor agonist , with dosing starting at 2.5 mg weekly and titrating to 15 mg weekly
"Weight management is multifactorial and involves genetics, hormones, mental health, diet, physical activity and social factors." While Wegovy is currently the big player in the field in New Zealand, "There are other medications or treatments available and more medications are expected to be available soon," she said
Early clinical data suggests higher rates of gastrointestinal side effects overall, with both constipation and diarrhea being common, sometimes alternating in the same user
Flow Wellness helps patients create individualized long-term plans based on their health goals and response to treatment
